RedHill Biopharma secures $60m licensing agreement with Hyloris for global commercialization of RHB-102

Pallavi Madhiraju- February 25, 2025 0

RedHill Biopharma Ltd. has entered into an exclusive licensing agreement with Hyloris Pharmaceuticals SA, granting the Belgian company the rights to develop and commercialize RHB-102 ... Read More